She was diagnosed with multiple
myeloma, a type of blood cancer that affects the plasma cells.
她被诊断出患有多发性骨髓瘤，这是一种影响浆细胞的血液癌症。
The treatment for
myeloma often involves chemotherapy and stem cell transplantation.
治疗多发性骨髓瘤通常包括化疗和干细胞移植。
Her
myeloma is in remission after months of aggressive chemotherapy.
经过几个月的强烈化疗，她的多发性骨髓瘤已进入缓解期。
He underwent a bone marrow biopsy to confirm the presence of
myeloma cells.
他接受了骨髓活检以确认存在多发性骨髓瘤细胞。
The patient's
myeloma has progressed, necessitating a change in their treatment plan.
患者的多发性骨髓瘤病情恶化，需要调整治疗方案。
Support groups are essential for people living with
myeloma, as they face emotional challenges as well.
对于患有多发性骨髓瘤的人来说，支持团体至关重要，因为他们也面临情感挑战。
Myeloma researchers are constantly exploring new therapies, hoping to find more effective cures.
多发性骨髓瘤的研究人员正在不断探索新的疗法，希望找到更有效的治疗方法。
The side effects of
myeloma treatment can be severe, but the benefits often outweigh them.
多发性骨髓瘤治疗的副作用可能很严重，但其益处通常大于风险。
She bravely fought against her
myeloma, inspiring many with her resilience and determination.
她勇敢地对抗多发性骨髓瘤，以她的坚韧和决心鼓舞了许多人。
His doctor recommended a clinical trial for a promising new drug in the treatment of
myeloma.
他的医生建议他参加一项治疗多发性骨髓瘤的有前景新药的临床试验。
The United States Food and Drug Administration on Monday approved CAR-T, a tumor immunotherapy, to treat adults with multiple myeloma.
美国食品和药物管理局周一批准了CAR-T，一种肿瘤免疫疗法，用于治疗成人多发性骨髓瘤。
A total of 20 star products, including Sarclisa, for treatment of relapsed multiple myeloma, and Coplavix, for the prevention of atherosclerotic thrombosis in adult patients with acute coronary syndrome who have taken clopidogrel and aspirin, and three other consumer health products will be displayed for the first time.
共有20款明星产品将首次展出，包括治疗复发性多发性骨髓瘤的Sarclisa、预防服用氯吡格雷和阿司匹林的成年急性冠状动脉综合征患者动脉粥样硬化血栓形成的Coplavix，以及其他三款消费类健康产品。
The company's oral drug Selinexor, which works in a mechanism different from all existing approved therapies, was approved on July 29 in South Korea, the first overseas market in Asia, to treat relapsed/refractory multiple myeloma and relapsed/refractory diffuse large B-cell lymphoma, a form of cancer.
该公司的口服药物Selinexor采用了与所有现有批准疗法不同的机制，于7月29日在亚洲首个海外市场韩国获得批准，用于治疗复发/难治性多发性骨髓瘤和复发/难治性弥漫性大B细胞淋巴瘤，这是一种癌症形式。
On July 29, the company's oral drug Selinexor, which works in a mechanism different from all the existing approved therapies, was approved in South Korea, the first overseas market in Asia, to treat relapsed/refractory multiple myeloma and relapsed/refractory diffuse large B-cell lymphoma.
在7月29日，该公司研发的口服药物Selinexor获得批准，在亚洲首个海外市场——韩国上市，用于治疗复发/难治性多发性骨髓瘤和复发/难治性弥漫大B细胞淋巴瘤。这款药物的作用机制与现有所有已获批疗法均不相同。
Sean Shan, president of Takeda China, said that an innovative therapy treating multiple myeloma, the second most common malignant tumor in the blood system, obtained regulatory approval in April last year and was launched on the market in July 2018, a year in advance from the company's estimated timeframe thanks to the healthcare reforms.
Another example is that Takeda launched an innovative medicine for the treatment of multiple myeloma, a type of blood cancer, last year.
未经许可，严禁转发。QQ交流群：688169419